How Machine Learning and Multi-Omics Will Revolutionize Oncology Trials
Machine learning and multi-omics integration are reshaping oncology trials by enhancing patient stratification, real-time safety monitoring, and protocol adherence. This holistic approach, supported by 2024-2025 data, promises more precise, adaptive, and inclusive cancer research.
Robert Maxwell
Aug 22, 2025
breast cancer analytics
hypertension data insights
prostate cancer biomarkers
stroke outcome prediction
